Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy

The metabolic requirements of metastatic non-small cell lung (mNSCLC) tumors from patients receiving first-line platinum-doublet chemotherapy are hypothesized to imprint a blood signature suitable for survival prediction. Pre-treatment samples prospectively collected at baseline from a randomized ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Desirée, Sengupta, Arjun, Ding, Keyue, Ubeydullah, ER, Krishnaiah, Saikumari, Leighl, Natasha B., Shepherd, Frances A., Seymour, Lesley, Weljie, Aalim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409233/
https://www.ncbi.nlm.nih.gov/pubmed/32708705
http://dx.doi.org/10.3390/cancers12071926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409233/
https://www.ncbi.nlm.nih.gov/pubmed/32708705
http://dx.doi.org/10.3390/cancers12071926

Ejemplares similares